All News

Hospitals must use indicators in clinical/services and human resources to assess their staffing effectiveness under JCAHO standards

AstraZeneca comes under fire by Grey Panthers

Pfizer recently announced that it has received marketing approval from the US Food and Drug Administration for voriconazole (Vfend tablets) and voriconazole for injection (Vfend I.V.) for use in the treatment of invasive aspergillosis and the treatment of serious fungal infections caused by Scedosporium apiospermum and Fusarium spp in patients intolerant of, or refractory to, other therapy.

Avonex covered under Medicare's self-injectable policy

The US Food and Drug Administration (FDA) recently approved urofollitropin for injection, purified (Bravelle, Ferring Pharmaceuticals) for the treatment of infertility. Urofollitropin is a highly purified follicle-stimulating hormone derived from the urine of postmenopausal women

Pharmacists are facing a myriad of prescription discount cards in a high-stakes game

nacds launches pharmacy care index to aid patient compliance

nacds promotes pharmacy to his students

Medicare bill considers paying for oral cancer drugs

APA releases new guidelines to treat bipolar disorder.

Handheld devices let physicians compare drug prices when they are prescribing

NIOSH to publish safety alert related to cytotoxic drugs

Feds post quality of nursing homes on Web for consumers to comparison shop

Pharmacists feel they're gaining authority in some areas and lagging in others

PDUFA law renewal draws consumer protest

American Pain Society recommends using OxyContin to treat patients with arthritis.

Executives from Merck-Medco and Rite Aid speak at AMCP meeting on how to build constructive relationship with each other

drug topics selects costco as pharmacy chain of the year 2002

New Mexico law will allow psychologists to prescribe

New guidelines treat breast cancer.

NACDS proposes a one-card program but pharmacists have mixed reactions

pharmacy benefits trends in US

On March 8, 2002, the FDA announced the approval of interferon beta-1a (Rebif, Serono) for the treatment of relapsing forms of MS. The FDA based its approval on the results of two trials.

Community pharmacy rejected the Bush administration's new plan for Medicare Rx discount cards as a rehash of the first proposal unveiled in July, 2001.

An alphabet soup of suffixes has arisen for controlled-release drugs, increasing the potential for drug errors

There's an alphabet soup of titles for the pharmacy profession now

VA pharmacists may have to give up their prescriptive authority unless their state allows the practice

Walter Fitzgerald speaks on Third Party Contracting: Understanding the Deal at NCPA conference in Vegas 2002